Alex Y Chang

Professor

1973 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Alex Y Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Etoposide Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1973 2019

Development of a Liposomal Formulation of Acetyltanshinone IIA for Breast Cancer Therapy

Wang, Q., Luo, M., Wei, N., Chang, A. Y. & Luo, K. Q., Jan 1 2019, (Accepted/In press) In : Molecular Pharmaceutics.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Biological Availability
acetyltanshinone IIA
Zebrafish

Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: An international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742)

Ma, B. B. Y., Lim, W. T., Goh, B. C., Hui, E. P., Lo, K. W., Pettinger, A., Foster, N. R., Riess, J. W., Agulnik, M., Chang, A. Y., Chopra, A., Kish, J. A., Chung, C. H., Adkins, D. R., Cullen, K. J., Gitlitz, B. J., Lim, D. W., To, K. F., Chan, K. C. A., Lo, Y. M. D. & 5 others, King, A. D., Erlichman, C., Yin, J., Costello, B. A. & Chan, A. T. C., Jan 1 2018, In : Journal of Clinical Oncology. 36, 14, p. 1412-1418 7 p.

Research output: Contribution to journalArticle

Multicenter Studies
Survival Rate
Ligands
Disease-Free Survival
Biomarkers

Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma

Hsu, C. L., Lui, K. W., Chi, L. M., Kuo, Y. C., Chao, Y. K., Yeh, C. N., Lee, L. Y., Huang, Y., Lin, T. L., Huang, M. Y., Lai, Y. R., Yeh, Y. M., Fan, H. C., Lin, A. C., Lu, Y. J., Hsieh, C. H., Chang, K. P., Tsang, N. M., Wang, H. M., Chang, A. Y. & 2 others, Chang, Y. S. & Li, H. P., Sep 20 2018, In : Journal of Experimental and Clinical Cancer Research. 37, 1, 233.

Research output: Contribution to journalArticle

Cyclin-Dependent Kinases
Heterografts
Pharmaceutical Preparations
Cyclin D1
Neoplasms
Non-Small Cell Lung Carcinoma
Action Potentials
Biomarkers
Growth
Cell Line

Non-invasive detection of actionable mutations in advanced non-small-cell lung cancer using targeted sequencing of circulating tumor DNA

Sim, W. C., Loh, C. H., Toh, G. L. X., Lim, C. W., Chopra, A., Chang, A. Y. & Goh, L. L., Oct 1 2018, In : Lung Cancer. 124, p. 154-159 6 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Mutation
DNA
Neoplasms
Genes